Institutional Handbook of Operating Procedures

Policy 09.13.47
Section: Clinical Responsible Vice President: EVP & CEO Health System

Subject: General Clinical Procedures and Care Responsible Entity: Trauma Services & Transfusion Services

I. Title
Massive Transfusion Protocol-Adult and Obstetric

II. Policy
A. The Massive Transfusion Protocol (MTP) is a multidisciplinary process whereby blood and
blood products can be rapidly obtained for an exsanguinating patient. The need for rapid
response time places a premium on rapid and effective communication.

B. This protocol applies to conditions warranting massive transfusion. Such conditions include
hemorrhage following significant trauma, GI bleeds, postpartum bleeding, significant
intraoperative blood loss and other similar clinical scenarios.

C. MTP activation criteria includes but is not limited to the following:

1. Assessment of Blood Consumption (ABC) score of two or more of the following:
a) Systolic blood pressure < 90 mmHg (0 = No, 1 = Yes)
b) Heart Rate > 120 bpm (0 = No, 1 = Yes)
c) Penetrating mechanism (0 = No, 1 = Yes)
d) Positive fluid on abdominal ultrasound – FAST Exam (0 = No, 1 = Yes)
2. Substantial blood loss (>1500 mLs or 6 units of PRBCs) with anticipated ongoing
hemorrhage in a short period of time (minutes to hours).
3. Greater than 50% loss of blood volume in 3 hours.
4. Transfusion of greater than 3 units of packed red blood cells within 1 hour – defined as
the critical administration threshold.
5. Persistent hemodynamic instability in the setting of uncontrolled bleeding.
6. Active bleeding requiring operation or another procedure to stop the bleeding.
7. Heart rate to systolic blood pressure greater than 1.4 – known as the Shock Index

D. Goals for patients at risk for ongoing bleeding is to achieve a core temp temperature of >35.9,
pH >7.3 and achieve hemostasis.

E. The decision to activate MTP can only be made by a Faculty physician. A resident or any other
staff member can be delegated to make the notification call to the Transfusion Service provided
that the authorizing faculty physician’s name is stated.

F. In the event blood is needed prior to completion of testing, the ordering physician must sign the
Emergency Release of Blood Products waiver found on the Blood Bank Division Primary
Request form (Form BB10) for uncrossmatched blood to be dispensed. This signature can be
obtained after the emergency release of products.

Page 1 of 12
 IHOP Policy 09.13.47

G. UTMB has two protocols with component ratios based on type of activation and campus.
1. Adult Activation
2. Obstetric Activation

H. Blood Product Availability

1. 4 uncrossmatched O negative and 4 uncrossmatched O positive packed red blood cell units
are available for immediate use in the Galveston Campus Emergency Department. Notify the
Transfusion Service immediately when blood is removed from the trauma bay refrigerator.
The units will be restocked from the Blood Bank inventory by the Transfusion Service staff.
2. The Transfusion Service department at each campus has pre-tagged universally
compatible group O packed red blood cell units and pre-thawed group A plasma units
available for immediate issue of Round 1 products.
3. Components are issued by the Transfusion Service in an established packed red
blood cells (pRBCs) to plasma ratio, 1:1, on each round according to campus for
adult and obstetric MTP activations.

Adult and Obstetric MTP Activation

Each
Galveston League City Angleton-Danbury Clear Lake
Round
pRBCs 6 3 3 3

Plasma 6 3 3 3

4. At each campus, 1 apheresis platelet dose (PLT) is issued on Round 1 and 1

cryoprecipitate dose (Cryo) is issued on Round 2 for adult MTP activations. Rounds
repeat as necessary with platelets on odd numbered rounds and cryo on even numbered
rounds. Products are continuously prepared until deactivation notice.

Adult MTP Activation

Each
Round 1 Round 2
Campus
Platelets 1 dose ---------

Cryoprecipitate --------- 1 dose

5. At each campus, 1 cryoprecipitate dose is issued on every round for obstetric MTP
activations. The first cryo dose may be issued after all other Round 1 products are
issued to allow component processing time to thaw the product. Rounds repeat as
necessary with platelets on odd numbered rounds.
Note: The next round of MTP is prepared once the previous round is picked up. Products
are prepared until deactivation notice or after 1 hr of no request for blood products.

2
 IHOP Policy 09.13.47

Obstetric MTP Activation

Each
Round 1 Round 2
Campus
Platelets 1 dose ---------

Cryoprecipitate 1 dose 1 dose

I. Potential Therapeutic Adjuncts to consider in MTP

1. Tranexamic Acid (TXA): Tranexamic acid (TXA) is a potential adjunct therapy during
MTP cases.
a. Tranexamic acid should not be mixed with blood transfusion or solutions
containing mannitol or penicillin
b. Trauma patients:
i. TXA must be given as early as possible (within 1-3 hours of injury) and is
ineffective if given three (3) hours after injury
ii. Loading dose of 1 gram of TXA should be given intravenously over 10
minutes (started within 3 hours of injury), followed by 1 gram over the
next 8 hours as a continuous infusion
c. Obstetric patients: clinically diagnosed post-partum hemorrhage patients should
receive:
i. 1 g in 10 ml (100 mg/ml) TXA intravenously as soon as possible and no
more than 3 hours after childbirth
ii. A second dose of 1 gm should be given intravenously if bleeding
continues after 30 minutes or restarts within 24 hours of the first dose

III. Procedures
A. Initiating the Massive Transfusion Protocol
1. Faculty physician declares the need to activate MTP and calls the Transfusion Service or
delegates a team member to make the notification call. Residents or any other
staff members can make the activation call provided that the authorizing faculty
physician’s name is stated.
2. Provide the Transfusion Service with the following information:
a. Patient’s name and MRN
b. Current location
c. Activating physician’s name (not a resident’s name)
d. Contact person’s name and phone extension
e. Patient’s age and gender
f. Case type (Trauma, Obstetric, GI bleed, other)
g. Pediatric Weight (if pediatric)
3. A patient care team delegate notifies the Clinical Operations Administrator (COA).

B. Blood Product Dispensing Process

1. The unit will delegate a runner to send for pick up blood from the Transfusion Service
department with a Blood Bank Dispensing Request (Form BB20) and a patient label that
includes the patient’s full name and MRN at a minimum. Blood cannot be issued if the
patient’s full name and MRN are not provided. A blank dispensing request can be
provided by Blood Bank at the time of pickup if the runner does not have the form.
2. If unable to send a runner to pick up blood, notify the COA to assist with blood transport
3
 IHOP Policy 09.13.47

and provide the patient’s name, MRN, current location, and a contact phone number.
3. Runner will complete blood read-back verification process with Blood Bank team
member. Continuous rounds of blood components will be prepared by Blood Bank and
will be picked up by a blood runner until deactivation notice is received.
4. The goal of the Transfusion Service is to have at least 1 MTP cooler ahead for the
duration of the MTP activation.

C. Transportation of Blood Products

1. Each product round will be issued and transported in an MTP specific cooler on wheels.
2. MTP coolers should be delivered immediately and directly to the bedside clinician. A
cooler shoulder strap is available upon request if needed to aid in transport via stairs.
3. Only remove products from the cooler when ready to verify and/or transfuse and be
certain to close the lid. MTP coolers are valid for 4 hours if the lid is not open.
4. If transferring an active MTP patient to another care area, the MTP cooler must
accompany the patient to the next location.
5. Communicate any patient location change to the Transfusion Service and provide
a contact person’s name and phone number in the receiving patient care area.

D. Compatibility Testing Specimen

1. Collect a Type and Screen sample if one has not already been sent to Blood Bank.
a. Send specimen in a 4 mL lavender top EDTA vacutainer tube.
b. Send with the Epic test requisition if available or with a downtime test requisition
Blood Bank Division Primary Request form (Form BB10).
c. Specimen label must include patient’s full name and medical record number. No
Epic Beaker labels are acceptable for Blood Bank samples.
d. Collection information must be documented on the test requisition or on the
specimen label. The collector’s identification along with the date and time of
collection are required.
2. A second specimen will be required if the patient has no blood type history on file. This
specimen must be drawn at a different time to ensure that patient identification was
performed twice. If a second sample is needed, the Blood Bank will notify the patient
care team and provide the pink top collection tube.
a. Send specimen in the 2 mL pink top EDTA vacutainer tube provided by Blood
Bank.
b. Send with a reprinted Epic Type and Screen test requisition if available or with a
downtime test requisition Blood Bank Division Primary Request form (Form
BB10).
c. Specimen label must include patient’s full name and medical record number. No
Epic Beaker labels are acceptable for Blood Bank samples.
d. Collection information must be documented on the test requisition or on the
specimen label. The collector’s identification along with the date and time of
collection are required.

IV. Documentation of Blood Product Transfusion During MTP

A. Emergency Room Workflow
1. The transfusionist and a second verifier must complete the dual sign off, date, and time on
the Blood Transfusion Record Tag of each unit to be transfused.
2. Transfused components should be entered in the Epic ED or Trauma narrator.
a. In the Epic ED or Trauma narrator, select Procedures, then
Blood-Unverified/MTP.
4
 IHOP Policy 09.13.47

b. Under Unverified Blood or Massive Transfusion Protocol, select the button for
the component to be transfused (Packed Red Blood Cells, Fresh Frozen Plasma,
Cryoprecipitate, Platelets). See image below.

c. Click the comment box next to “Unit Number - Scan Barcode into Comments” in
the section for the correct component to be scanned (Packed Red Blood Cells,
Fresh Frozen Plasma, Cryoprecipitate, Platelets). See image below

d. Scan the component barcode on the product to be transfused.

e. Verify that information entered in the comment field matches the donor unit
barcode number on the blood bag.
f. Accept the comment by clicking the green check.
g. Select “1” in the same section to document the 1 unit to be given.
h. No stop time is recorded because products are rapidly transfused.
i. Indicate if there are signs/symptoms consistent with a possible transfusion
reaction by answering the suspected reaction question either Yes or No.
j. Repeat for each transfused component
3. If there is a software workflow issue, do not delay the transfusion but complete all
documentation on the Blood Transfusion Record Tag (Downtime Form).
4. The Blood Transfusion Record Tag (Downtime Form) must always be placed in the patient’s
paper chart as a permanent record.
5. Enter vitals as necessary per transfusion policy IHOP 9.13.29.
6. The blood product volume is printed on the transfusion record tag.
7. Use of the Level 1 Rapid Infusor
a. https://www.youtube.com/watch?v=Ldzajt2OugY
Single use tubing comes pre-packaged in sterile container
i. Types of products that can be used in the Level I rapid infuser
 Crystalloids
 Colloids
 Packed Red Blood Cells
5
 IHOP Policy 09.13.47

ii. Do NOT use the level I to warm and transfuse the following:
 Platelets
 ii.cryo-precipitates
 Granulocyte suspensions

iii. Do NOT mix the following with blood products:

 Lactated Ringers solution
 Dextrose in water
 Hypotonic sodium chloride solutions

8. Operational Safety Checklist

a. RN MUST remove all air from fluid bags before spiking fluid lines and
connecting to the patient. Failure can result in infusion of air to the patient.
b. Replace the gas vent/filter assembly every 3 hours or if filter becomes clogged or
when air is slowly vented. Gas vent/filter must be fully primed before continuing
infusion. Failure to prime adequately can result in infusion of air to the patient.
c. Do NOT use in high-energy fields such as: MRI, X-RAY, portable and mobile
RF communications equipment. The fluid warmer may act as a projectile in a
strong magnetic field, causing artifacts or not function as intended.
d. Do NOT bend heat exchanger-this can cause damage between recirculating
solution and IV fluid path resulting in the inappropriate delivery of fluids.
e. Do NOT reuse partially full fluid bags as these could contain air causing an
infusion of air to the patients. Use only new fluid bags after the air has been
removed aseptically.
f. An activation of the over temperature warning signal indicates that warming has
stopped and immediate intervention is required. Failure to do so can result in
harm to the patient.
g. Ensure the tubing is properly placed in the air detector/clamp slot. Failure to do so
correctly may result in air infusion.
h. Alarm for the air detector/clamp signals that fluid has stopped, and immediate
intervention is required. Disconnect tubing from patient, remove air. Failure to do
so can result in injury to patient.
i. Ensure the functional test of the air detector/clamp accessory before each use.
Failure of any visual indicator that does not illuminate or no audible sound is
noted-DO NOT USE the fluid warmer. Tag equipment and notify CES 2-4040

B. Inpatient Workflow
1. The transfusionist and a second verifier must complete the dual sign off, date, and time on
the Blood Transfusion Record Tag of each unit to be transfused.
2. Transfused components should be entered into the Blood Administration Flowsheet in Epic
a. Go to the Blood Administration flowsheet.
b. Select Add Column, then select the row titled Unverified Blood or Massive
Transfusion Protocol. See image below.

6
 IHOP Policy 09.13.47

c. Select the component type (Packed Red Blood Cells, Fresh Frozen Plasma,
Cryoprecipitate, Platelets). See image below.

d. Select “Unit Number - Scan Barcode Into Comments” in the row name for the
component to be scanned (Packed Red Blood Cells, Fresh Frozen Plasma,
Cryoprecipitate, Platelets).
e. Place the cursor in the “comment (F6)” box.
f. Scan the component barcode on the product to be transfused.
g. Verify that information entered in the comment field matches the donor unit
barcode number on the blood bag.
h. Select “1” in the row details box to document the 1 unit to be given.
i. No stop time is recorded because products are rapidly transfused.
j. Indicate if there are signs/symptoms consistent with a possible transfusion
reaction by answering the suspected reaction question either Yes or No.
k. Repeat for each transfused unit
3. If there is a software workflow issue, do not delay the transfusion but complete all
documentation on the Blood Transfusion Record Tag (Downtime Form).
4. The Blood Transfusion Record Tag must always be placed in the patient’s paper chart as a
permanent record.
5. Enter vitals as necessary per IHOP 9.13.29 Transfusion policy.
6. The blood product volume is printed on the transfusion record tag.
7. Use of the Level 1 Rapid Infusor
a. https://www.youtube.com/watch?v=Ldzajt2OugY
Single use tubing comes pre-packaged in sterile container
i. Types of products that can be used in the Level I rapid infuser:
 Crystalloids
 Colloids
 Packed Red Blood Cells

ii. Do NOT use the level I to warm and transfuse the following:
 Platelets
 cryo-precipitates
 Granulocyte suspensions
iii. Do NOT mix the following with blood products:
 Lactated Ringers solution
 Dextrose in water
7
 IHOP Policy 09.13.47

 Hypotonic sodium chloride solutions

8. Operational Safety Checklist

a. RN MUST remove all air from fluid bags before spiking fluid lines and
connecting to the patient. Failure can result in infusion of air to the patient.
b. Replace the gas vent/filter assembly every 3 hours or if filter becomes clogged or
when air is slowly vented. Gas vent/filter must be fully primed before continuing
infusion. Failure to prime adequately can result in infusion of air to the patient.
c. Do NOT use in high-energy fields such as: MRI, X-RAY, portable and mobile
RF communications equipment. The fluid warmer may act as a projectile in a
strong magnetic field, causing artifacts or not function as intended.
d. Do NOT bend heat exchanger-this can cause damage between recirculating
solution and IV fluid path resulting in the inappropriate delivery of fluids.
e. Do NOT reuse partially full fluid bags as these could contain air causing an
infusion of air to the patients. Use only new fluid bags after the air has been
removed aseptically.
f. An activation of the over temperature warning signal indicates that warming has
stopped and immediate intervention is required. Failure to do so can result in
harm to the patient.
g. Ensure the tubing is properly placed in the air detector/clamp slot. Failure to do so
correctly may result in air infusion.
h. Alarm for the air detector/clamp signals that fluid has stopped, and immediate
intervention is required. Disconnect tubing from patient, remove air. Failure to do
so can result in injury to patient.
i. Ensure the functional test of the air detector/clamp accessory before each use.
Failure of any visual indicator that does not illuminate or no audible sound is
noted-DO NOT USE the fluid warmer. Tag equipment and notify CES 2-4040

C. Operating Room Workflow

1. The transfusionist and a second verifier must complete the dual sign off, date, and time on
the Blood Transfusion Record Tag.
a. Verification time is recognized as the unit start time.
2. Transfused components should be entered into flowsheets in Epic. See image below.

3. Click the I/O button

4. Select the component type (Packed Red Blood Cells, Fresh Frozen Plasma, Cryoprecipitate,
Platelets). See image below.

8
 IHOP Policy 09.13.47

a. No stop time is recorded because products are rapidly transfused.

b. The blood product volume is printed on the transfusion record tag.
5. Indicate if there are signs/symptoms consistent with a possible transfusion reaction by
answering the suspected reaction question either Yes or No.
a. If there is a software workflow issue, do not delay the transfusion but complete all
documentation on the Blood Transfusion Record Tag (Downtime Form).
b. The Blood Transfusion Record Tag (Downtime Form) must always be placed in
the patient’s paper chart as a permanent record.

6. Use of the Belmont Rapid Infuser

a. https://www.youtube.com/watch?v=A6jn4X4BvHs
Single patient use disposable comes preassembled in a Sterile container and is
color coded for easy installation.

i. The system should not be used to warm:

 Platelets
 Cryoprecipitate
 Granulocyte suspensions

ii. Do not mix the following with blood products:

 Lactated Ringers solution
 Dextrose in water
 Hypotonic sodium chloride solutions

iii. Operational Safety Checklist:

 Do not use solutions containing calcium or other additives that
would compromise the anticoagulants in the blood products. Clots
in blood products may block the flow and cause overheating.
 Do not use the device if temperature probes or disposable set
windows are wet, dirty, or blocked as they can compromise the
accuracy of the temperature probes and cause the unit to call for an
increase of output temperature.
 Do not use fluids stored in overly high temperature fluid warming
cabinets. The use of prewarmed fluid is not necessary. Prewarmed
fluids that exceed the temperature limit will trigger an over-
temperature alarm.
 In the event that the unit has displayed an overheat or over-
temperature indication, discard and replace the disposable and
blood product.

9
 IHOP Policy 09.13.47

 Assure an optimal infusion site with sufficient flow capability and

appropriate cannula bore size to avoid over-pressure indication.
 Assure that bags have fluid in them.

V. MTP Overview
A. Nursing Responsibilities
1. Verify that an authorization is completed for MTP by ordering faculty.
a. If using non-crossmatched blood-verify that the ordering faculty has completed
the emergency release of blood products waiver.
2. Document and monitor vital signs in accordance with IHOP policy 9.13.29
3. Document and monitor urine output
4. Ensure the patient has at least 2 working large bore intravenous catheters (IV) catheters for
use with the MTP protocol and use with the rapid infuser.

a. Ensure a dedicated intravenous line for use with each type of blood product.
b. Types of products that can be used in the Level I rapid infuser:
i. Crystalloids
ii. Colloids
iii. Packed Red Blood Cells

c. Allotted operation time per blood product for tubing usage:

i. Up to 4 hours or 4 units of the same blood product or whichever
comes first.
ii. No allowance for use of piggyback IV administration
iii. Platelets should NOT be run through a Y set previously used for RBC
transfusion - The platelets will get trapped in the filter.

5. Activating MTP
a. Notify transfusion services that MTP has been ordered and activated and provide
the following information to the transfusionist
i. Ordering faculty’s name
ii. Patient name and MRN
iii. Current location
iv. Patient’s age and gender
v. Case type (Examples: trauma, obstetric, GI bleed)
vi. Pediatric weight (for pediatric cases)
 Notify the COA of the MTP activation.
vii. Perform an ongoing assessment to monitor for signs of a transfusion
reaction. See IHOP policy 9.13.29.
viii. Monitor for signs and symptoms of fluid overload
ix. Monitor and assess for pain
x. Provide education to patient and family members related to current
plan of care for the patient receiving MTP

B. Epic Downtime Workflow

1. The Blood Transfusion Record Tag must be completed for each unit transfused and placed in
the patient’s chart.
2. The following must be recorded:
a. Dual signature verification
b. Vitals
10
 IHOP Policy 09.13.47

c. Start time
d. Volume transfused
e. Any signs or symptoms consistent with a possible transfusion reaction

C. MTP Labs Order Set

1. Order stat pack labs to be collected after the infusion of each cooler shipment.
a. Hemogram- (CBC without differential)
b. Prothrombin time/ INR- (PT)
c. Activated Partial Thromboplastin Time- (aPTT)
d. Fibrinogen
e. Ionized calcium
2. Vacutainer tubes are provided with each product shipment inside a clear zippered
pouch attached to the cooler. A red instruction card is also included.
3. Collect the labs after the infusion of each round. Label the tubes appropriately and
send to the Lab with the red card for stat processing.
4. Transfusion Medicine physicians monitor these lab values during the case and
may modify the component quantities given based on the results.

D. Terminating the Massive Transfusion Protocol

i. Faculty physician declares the need to terminate MTP and calls the Transfusion Service
or delegates a team member to make the deactivation call.
ii. This call should be made immediately so the Transfusion Service can cease component
preparation and prevent excessive product wastage.
iii. MTP will automatically be deactivated if last round picked up is >1hr.

E. Blood Product and Cooler Return Process

i. Heavily soiled coolers need to be wiped clean with a facility approved disinfectant prior
to being returned to the Transfusion Service.
ii. Send a runner to return any remaining coolers and any unused blood products to the
Transfusion Service.
iii. If any units were taken from the cooler and not transfused, do not place back in cooler
and do not discard in the room. Unit(s) must be returned to the Transfusion Service for
final status update and proper disposal.

F. Performance Improvement Monitoring

i. Each MTP activation is reviewed, and a post MTP utilization meeting is held to discuss
any issues encountered during the case.
ii. Invitees include the activating physician, Transfusion Medicine physicians, and
representatives from Transfusion, Trauma, and Nursing Services.
iii. The intent of the meeting is educational with goals to identify opportunities for process
improvement, increase the awareness of goal-directed transfusion therapy, and to
improve the appropriateness of MTP activations.

VI. Related UTMB Policies and Procedures

IHOP - 09.13.24 - Patient Identifiers
IHOP - 09.13.29 - Transfusion of Blood Components
IHOP - 09.03.17 - Consent - Overview and Basic Requirements

11
 IHOP Policy 09.13.47

VII. Additional References

BLOOD AND FLUID PRESSURE INFUSERS
BLOOD PRODUCT ADMINISTRATION MASSIVE TRANSFUSION
Massive Transfusion Protocol- Galveston
Massive Transfusion Protocol- Angleton-Danbury
Massive Transfusion Protocol- Clear Lake
Massive Transfusion Protocol- League City
ACS TQIP Massive Transfusion in Trauma Guidelines
Dever, C. M. (2017). Use of a massive infusion device and a pressure infusor bag. In D. L. Weigand
(Eds.), AACN Procedure manual for high acuity, progressive, and critical care (7th ed., pp. 1088-1099).
Elsevier

VIII. Dates Approved or Amended

Originated: 02/27/2023
Reviewed with Changes Reviewed without Changes

IX. Contact Information

Galveston Campus League City Campus Angleton-Danbury Campus Clear Lake Campus
Transfusion Services Transfusion Services Transfusion Services Transfusion Services
(409) 772-8284 (832) 505-3114 (979) 864-8149 (832) 632-7014
Trauma Services Trauma Services Trauma Services Trauma Services
(409) 747-0152 (832) 505-9785 (979) 849-7721 832-635-7496

12